Dougherty & Co Upgrades Dolby Laboratories (DLB) to Buy
Get Alerts DLB Hot Sheet
Rating Summary:
4 Buy, 5 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Join SI Premium – FREE
Dougherty & Co upgraded Dolby Laboratories (NYSE: DLB) from Neutral to Buy with a price target of $38.
Analyst Steven Frankel said, "On the heels of a solid Q1 performance where the company posted 3% revenue growth, reiterated its full year guidance, and showed material progress across its three key new initiatives, we are raising our rating on Dolby from Neutral to Buy. For the first time in the last couple of years, we are more optimistic and believe the current valuation of 13.7x our CY16 EPS estimate (ex-SBC) and just 11.1x excluding the company's $8.61/share in cash, represents an excellent entry point for this improving story. Our Price Target is $38, which is based on 12.5x CY16 EPS, plus the cash on the balance sheet."
For an analyst ratings summary and ratings history on Dolby Laboratories click here. For more ratings news on Dolby Laboratories click here.
Shares of Dolby Laboratories closed at $31.73 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi Upgrades United Microelectronics Corp (2303:TT) (UMC) to Buy 'with limited downside'
- Piper Sandler Upgrades SmartFinancial (SMBK) to Overweight 'on Risk/Reward Dynamic for Clean Bank Under TBVPS'
- RBC Capital Upgrades Galp Energia SGPS SA (GALP:LI) (GLPEF) to Outperform
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS View, UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!